Velliou, M.; Markos, L.; Qiuris, S.; Bezati, S.; Ventoulis, I.; Matsiras, D.; Bistola, V.; Ikonomidis, I.; Polyzogopoulou, E.; Parissis, J.T.
Prevalence of Transthyretin Amyloid Cardiomyopathy Among Acute Heart Failure Patients with Hypertrophy Across the Left Ventricular Ejection Fraction Spectrum. J. Clin. Med. 2024, 13, 7103.
https://doi.org/10.3390/jcm13237103
AMA Style
Velliou M, Markos L, Qiuris S, Bezati S, Ventoulis I, Matsiras D, Bistola V, Ikonomidis I, Polyzogopoulou E, Parissis JT.
Prevalence of Transthyretin Amyloid Cardiomyopathy Among Acute Heart Failure Patients with Hypertrophy Across the Left Ventricular Ejection Fraction Spectrum. Journal of Clinical Medicine. 2024; 13(23):7103.
https://doi.org/10.3390/jcm13237103
Chicago/Turabian Style
Velliou, Maria, Lampros Markos, Stella Qiuris, Sofia Bezati, Ioannis Ventoulis, Dionysis Matsiras, Vasiliki Bistola, Ignatios Ikonomidis, Effie Polyzogopoulou, and John T. Parissis.
2024. "Prevalence of Transthyretin Amyloid Cardiomyopathy Among Acute Heart Failure Patients with Hypertrophy Across the Left Ventricular Ejection Fraction Spectrum" Journal of Clinical Medicine 13, no. 23: 7103.
https://doi.org/10.3390/jcm13237103
APA Style
Velliou, M., Markos, L., Qiuris, S., Bezati, S., Ventoulis, I., Matsiras, D., Bistola, V., Ikonomidis, I., Polyzogopoulou, E., & Parissis, J. T.
(2024). Prevalence of Transthyretin Amyloid Cardiomyopathy Among Acute Heart Failure Patients with Hypertrophy Across the Left Ventricular Ejection Fraction Spectrum. Journal of Clinical Medicine, 13(23), 7103.
https://doi.org/10.3390/jcm13237103
